Evidence map›Paper›PMID 22730461›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2012

Genetic and functional analyses implicate the NUDT11, HNF1B, and SLC22A3 genes in prostate cancer pathogenesis.

Chiara Grisanzio, Lillian Werner, David Takeda, Bisola C Awoyemi, Mark M Pomerantz, Hiroki Yamada, Prasanna Sooriakumaran, Brian D Robinson, Robert Leung, Anna C Schinzel and 15 more

Open access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 77 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
77citing papers in PubMed, 3 pooled it
8.5field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

77 citing papers in PubMed, 3 syntheses or guidelines pooled it, 109 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Distributed eQTL analysis with auxiliary information.Journal of statistical planning and inference · 2024
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. A multiple-testing procedure for high-dimensional mediation hypotheses.Journal of the American Statistical Association · 2022
    Article
  19. Article
  20. Article

17 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

25 authors at 10 institutions in 4 countries.

Chiara GrisanzioDepartment of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02115, USA.
Lillian Werner
David Takeda
Bisola C Awoyemi
Mark M Pomerantz
Hiroki Yamada
Prasanna Sooriakumaran
Brian D Robinson
Robert Leung
Anna C Schinzel
Ian Mills
Helen Ross-Adams
David E Neal
Masahito Kido
Toshihiro Yamamoto
Gillian Petrozziello
Edward C Stack
Rosina Lis
Philip W Kantoff
Massimo Loda
Oliver Sartor
Shin Egawa
Ashutosh K Tewari
William C Hahn
Matthew L Freedman
Cornell University · USJikei University School of Medicine · JPCancer Research UK · GBDana-Farber Cancer Institute · USBrigham and Women's Hospital · USBroad Institute · USHarvard University · USPancreatic Cancer Action Network · USTulane University · USUniversity of Oslo · NO

Funding

Tumor and Circulating Markers as Links Between Obesity and Lethal Prostate CanceP50CA090381 · NCI · DANA-FARBER CANCER INSTITUTE · PI LODA, MASSIMO · 2002 to 2017
$36.2M
Physician Scientist Training in Cancer ResearchT32CA009172 · NCI · DANA-FARBER CANCER INSTITUTE · PI Jennifer R Brown, James A. DeCaprio · 1985 to 2026
$17.1M
Epidemiological and Clinical Translational Studies Post Genome-Wide AssociationU19CA148537 · NCI · UNIVERSITY OF SOUTHERN CALIFORNIA · PI EASTON, DOUGLAS FREDERICK, EELES, ROSALIND · 2010 to 2014
$10.4M
Fine mapping and characterization of the 8q24 prostate cancer risk locusR01CA129435 · NCI · DANA-FARBER CANCER INST · PI FREEDMAN, MATTHEW L · 2007 to 2009
$1.5M
Howard Hughes Medical InstituteMedical Research Council G0900871NCI NIH HHS 5P50CA90381NCI NIH HHS P50 CA090381NCI NIH HHS R01 CA129435NCI NIH HHS T32 CA009172NCI NIH HHS U19 CA148537
6 · The paper itself

Abstract

One of the central goals of human genetics is to discover the genes and pathways driving human traits. To date, most of the common risk alleles discovered through genome-wide association studies (GWAS) map to nonprotein-coding regions. Because of our relatively poorer understanding of this part of the genome, the functional consequences of trait-associated variants pose a considerable challenge. To identify the genes through which risk loci act, we hypothesized that the risk variants are regulatory elements. For each of 12 known risk polymorphisms, we evaluated the correlation between risk allele status and transcript abundance for all annotated protein-coding transcripts within a 1-Mb interval. A total of 103 transcripts were evaluated in 662 prostate tissue samples [normal (n = 407) and tumor (n = 255)] from 483 individuals [European Americans (n = 233), Japanese (n = 127), and African Americans (n = 123)]. In a pooled analysis, 4 of the 12 risk variants were strongly associated with five transcripts (NUDT11, MSMB, NCOA4, SLC22A3, and HNF1B) in histologically normal tissue (P ≤ 0.001). Although associations were also observed in tumor tissue, they tended to be more attenuated. Previously, we showed that MSMB and NCOA4 participate in prostate cancer pathogenesis. Suppressing the expression of NUDT11, SLC22A3, and HNF1B influences cellular phenotypes associated with tumor-related properties in prostate cancer cells. Taken together, the data suggest that these transcripts contribute to prostate cancer pathogenesis.

Indexed as

Gene Expression Regulation, NeoplasticAllelesGene Expression ProfilingGenome-Wide Association StudyHepatocyte Nuclear Factor 1-betaHumansMaleModels, GeneticNudix HydrolasesOrganic Cation Transporter 3Organic Cation Transport ProteinsPhenotypePolymorphism, GeneticPolymorphism, Single NucleotideProstatic NeoplasmsPyrophosphatasesHepatocyte Nuclear Factor 1-betaHNF1B protein, humanNudix HydrolasesNUDT11 protein, humanOrganic Cation Transporter 3Organic Cation Transport ProteinsPyrophosphatases

Identifiers

PMID22730461
PMCPMC3396469
OpenAlexW2044391680

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.